Medical Oncology

, Volume 15, Issue 3, pp 141–144

Recombinant human erythropoietin (rhEPO) in the prevention and treatment of chemotherapy-induced anaemia

Authors

  • MR Nowrousian
    • Department of Internal Medicine (Cancer Research), West German Cancer CenterUniversity of Essen Medical School
Editorial

DOI: 10.1007/BF02821932

Cite this article as:
Nowrousian, M. Med Oncol (1998) 15: 141. doi:10.1007/BF02821932

Keywords

anemia erythropoietin chemotherapy quality of life transfusion

Copyright information

© Stockton Press 1998